Finance

Lists
Why is 524372 down 2,50%?
Dive Deeper
524372:BOM
Orchid Pharma Ltd
923,75 ₹
-2,50%
(-23,70) 1D
15 қаз., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524372...
Open
945,05 ₹
High
948,00 ₹
Low
923,75 ₹
Mkt. cap
55,39 млрд
Avg. vol.
6,88 мың
Volume
4,05 мың
52-wk high
1 142,65 ₹
52-wk low
471,30 ₹
No. of employees
1 мың
Open
945,05 ₹
High
948,00 ₹
Low
923,75 ₹
Mkt. cap
55,39 млрд
Avg. vol.
6,88 мың
Volume
4,05 мың
52-wk high
1 142,65 ₹
52-wk low
471,30 ₹
No. of employees
1 мың
News stories
From web sources and news partners
Profile
Orchid Pharma Limited is an Indian pharmaceutical company based in Chennai. It was founded by Kailasam Raghavendra Rao on 1 July 1992. Orchid Pharma is the only pharma company in India to have discovered a New Drug Enmetazobactam which is now approved in United States, Europe and India. Wikipedia
About Orchid Pharma Ltd
CEO-
Employees1,17 мың
Founded1992
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
1,94 млрд
2,07 млрд
6,59 млрд
3,04 млрд
Cost of goods sold
1,33 млрд
1,43 млрд
5,03 млрд
2,04 млрд
Cost of revenue
1,33 млрд
1,43 млрд
5,03 млрд
2,04 млрд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
248,51 млн
241,28 млн
502,27 млн
280,38 млн
Operating expense
713,95 млн
715,86 млн
1,40 млрд
968,16 млн
Total operating expenses
2,04 млрд
2,15 млрд
6,43 млрд
3,01 млрд
Operating income
-103,77 млн
-74,65 млн
163,81 млн
30,51 млн
Other non operating income
107,74 млн
56,09 млн
-238,03 млн
18,28 млн
EBT including unusual items
-57,24 млн
-126,14 млн
131,94 млн
32,97 млн
EBT excluding unusual items
-57,24 млн
-55,01 млн
54,86 млн
32,97 млн
Income tax expense
-
-
17,00 мың
723,00 м.
Effective tax rate
-
-
0,01%
2,19%
Other operating expenses
376,43 млн
384,29 млн
419,31 млн
578,29 млн
Net income
-57,24 млн
-126,14 млн
131,92 млн
32,24 млн
Net profit margin
-2,96%
-6,09%
2,00%
1,06%
Earnings per share
-1,13
-1,08
4,58
0,54
Interest and investment income
-
-
101,25 млн
-
Interest expense
-37,32 млн
-31,78 млн
-
-22,30 млн
Net interest expenses
-37,32 млн
-31,78 млн
101,25 млн
-22,30 млн
Depreciation and amortization charges
89,01 млн
90,29 млн
166,61 млн
109,49 млн
EBITDA
-15,99 млн
10,45 млн
269,63 млн
119,14 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары